These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Mode of action of the antitumor compound girodazole (RP 49532A, NSC 627434).
    Author: Colson G, Rabault B, Lavelle F, Zerial A.
    Journal: Biochem Pharmacol; 1992 Apr 15; 43(8):1717-23. PubMed ID: 1575768.
    Abstract:
    Girodazole (RP 49532A) or 3-amino-1-[4-(2 amino-1H-imidazolyl]-propanol, 2HCl is an experimental antitumor compound which inhibits protein synthesis in cell cultures and in cell free systems. The compound has been evaluated for its capacity to inhibit specific assays of initiation, elongation and termination of protein synthesis. Girodazole inhibited the release of nascent peptides from polyribosomes in rabbit reticulocyte lysates indicating that the major effect of the compound is on the protein synthesis termination step.
    [Abstract] [Full Text] [Related] [New Search]